- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.84 Å
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 2 residues within 4Å:- Chain A: Y.25, N.58
Ligand excluded by PLIPNAG.4: 3 residues within 4Å:- Chain A: N.119, T.121, N.122
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.161, N.162
- Chain B: I.465
Ligand excluded by PLIPNAG.6: 5 residues within 4Å:- Chain A: T.105, N.231, T.233
- Chain B: R.454, E.462
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: N.279
- Chain B: K.555
Ligand excluded by PLIPNAG.8: 2 residues within 4Å:- Chain A: N.328, Q.577
Ligand excluded by PLIPNAG.9: 2 residues within 4Å:- Chain A: N.600, T.601
Ligand excluded by PLIPNAG.10: 3 residues within 4Å:- Chain A: N.613, T.615, E.616
Ligand excluded by PLIPNAG.11: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain A: N.706
- Chain C: Y.793
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: N.714, Q.1068
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.798, S.800
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: A.703, N.1071
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain B: Y.25, T.26, N.27, N.58
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain B: N.119, T.121, V.124
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain B: T.105, N.231, T.233
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain B: N.279
- Chain C: K.555
Ligand excluded by PLIPNAG.22: 1 residues within 4Å:- Chain B: N.328
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain A: Q.892
- Chain B: E.1069, K.1070, N.1071
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.161, N.162
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: N.613, T.615, E.616
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain B: N.706
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.714
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.798, S.800
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.1131
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: Y.25, N.58
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: N.119, V.124
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain C: N.161, N.162
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: T.105, N.231
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: N.277, N.279
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: N.328, Q.577
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.613, T.615, E.616
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: Y.793
- Chain C: N.706
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.714
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: N.798, S.800, Q.801
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: K.1070, N.1071
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: N.1095, H.1098, F.1100
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.1131
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
S309 heavy chain: DF
S309 light chain: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
IF
JE
GG
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.84 Å
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
S309 heavy chain: DF
S309 light chain: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
IF
JE
GG
H